Intestinal barrier dysfunction as a therapeutic target for cardiovascular diseas

Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease.

Study Information

Am J Physiol Heart Circ Physiol. 2020 Dec 1;319(6):H1227-H1233. doi: 10.1152/ajpheart.00612.2020. Epub 2020 Sep 28. PMID: 32986965; PMCID: PMC7792706.

Full Study

https://pubmed.ncbi.nlm.nih.gov/32986965/

Recent news

Gut microbiota's role in the enhancement of type 2 diabetes treatment by a tradi
Effects of probiotic, cinnamon, and synbiotic supplementation on glycemic contro
Antioxidative effects of Cinnamomi cassiae and Rhodiola rosea extracts in liver
Design, synthesis and biological evaluation of cinnamic acid derivatives with sy
Cinnamaldehyde attenuates streptozocin-induced diabetic osteoporosis in a rat mo
Recent news
Gut microbiota's role in the enhancement of type 2 diabetes treatment by a tradi
Effects of probiotic, cinnamon, and synbiotic supplementation on glycemic contro
Antioxidative effects of Cinnamomi cassiae and Rhodiola rosea extracts in liver
Design, synthesis and biological evaluation of cinnamic acid derivatives with sy
Cinnamaldehyde attenuates streptozocin-induced diabetic osteoporosis in a rat mo

Latest Articles

Is Your Immune System Ready for Winter? Antioxidants
Dr. Linda J. Dobberstein, DC, Board Certified in Clinical Nutrition

Is Your Immune System Ready for Winter?

View details
Does Your Protein Supplement Contain Lead? Protein
Dr. Linda J. Dobberstein, DC, Board Certified in Clinical Nutrition

Does Your Protein Supplement Contain Lead?

View details
Next-Generation Gut Support: Introducing the New Super Dophilus Allergies
Dr. Linda J. Dobberstein, DC, Board Certified in Clinical Nutrition

Next-Generation Gut Support: Introducing the New Super Dophilus

View details